A retrospective, observational study assessing efficacy of sequential use of Carfilzomib and Pomalidomide in relapsed Multiple Myeloma
Latest Information Update: 07 Jan 2021
At a glance
- Drugs Carfilzomib (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 07 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology